Antifungal activity of voriconazole on local isolates: An in-vitro study
- Author:
Karina Q. De Sagun-Bella
1
;
Archimedes Lee D. Agahan
1
;
Leo DP. Cubillan
1
,
2
;
Noel S. Carino
1
;
Roslyn De Mesa-Rodriguez
2
Author Information
- Publication Type:Journal Article
- Keywords: Antifungal susceptibility
- MeSH: Voriconazole; Amphotericin B; Candida; Fusarium; Aspergillus
- From: Philippine Journal of Ophthalmology 2013;38(1):29-34
- CountryPhilippines
- Language:English
-
Abstract:
Objective:To determine the in-vitro activity of voriconazole and compare it with amphotericin B, fluconazole,
itraconazole, ketoconazole, and caspofungin against local yeast and mold clinical isolates Candida albicans, Candida
sp., Aspergillus terreus, Aspergillus niger, and Fusarium cylindrocarpone.
Methods:Review of the Institute of Ophthalmology microbiology records were done and was the basis for the local isolates included in the study. Mean inhibitory concentration (MIC) was determined using YeastOne Sensititre Microtitre Colorimery method (TREK Diagnostic Systems, England). Two-way ANOVA, Duncan, and Pearson chi-squared tests were used to analyze the data.
Results:All isolates tested were sensitive to voriconazole. Eighty percent (80%) of the isolates were sensitive to amphotericin B and 25% showed resistance to itraconazole. Yeast pathogens were all sensitive to amphotericin B and voriconazole. More than 50% of the yeast pathogens were resistant to ketoconazole. Molds or filamentous fungi showed higher susceptibility to voriconazole than amphotericin B and the other antifungals.
Conclusion:Voriconazole exhibited good in-vitro activity against the isolates tested. It has the same efficacy on yeast pathogens (Candida albicans and Candida sp.) when compared with amphotericin B. It has superior efficacy on filamentous fungi (Aspergillus and Fusarium). There is a role for voriconazole in the treatment of ocular infections, especially in the setting of poor antifungal drug availability. - Full text:PJO 581.pdf
